The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
DNA topoisomerase II, genotoxicity, and cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid
WATSON, J. D., & CRICK, F. H. C. (1953) · Nature · doi:10.1038/171737a0 · Cited by 13,584
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
Genetical Implications of the Structure of Deoxyribonucleic Acid
WATSON, J. D., & CRICK, F. H. C. (1953) · Nature · doi:10.1038/171964b0 · Cited by 2,197
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
Rate of depurination of native deoxyribonucleic acid
Lindahl, T., & Nyberg, B. (1972) · Biochemistry · doi:10.1021/bi00769a018 · Cited by 1,556
Flavonoids in Food and Their Health Benefits
YAO, L. H., JIANG, Y. M., SHI, J., TOM�S-BARBER�N, F. A., DATTA, N., SINGANUSONG, R., & CHEN, S. S. (2004) · Plant Foods for Human Nutrition · doi:10.1007/s11130-004-0049-7 · Cited by 1,545
Genetical Implications of the Structure of Deoxyribonucleic Acid
Watson, J. D., & Crick, F. H. C. (2017) · Klassische Texte der Wissenschaft · doi:10.1007/978-3-662-47150-0_5 · Cited by 1,297
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Structure and mechanism of DNA topoisomerase II
Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996) · Nature · doi:10.1038/379225a0 · Cited by 859
Kurzer, M. S., & Xu, X. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.353 · Cited by 829
The antitumor activities of flavonoids.
Kandaswami, C. C., Kanadaswami, C., Lee, L., Lee, P.-P. H., Hwang, J.-J., Ke, F., Huang, Y.-T., & Lee, M. (2005) · PubMed · Cited by 758
Plasma concentrations of phyto-oestrogens in Japanese men
ADLERCREUTZ, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92188-y · Cited by 731
Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid
Watson, J. D., & Crick, F. H. C. (2004) · Resonance · doi:10.1007/bf02834980 · Cited by 656
Fluoroquinolone antimicrobial agents
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.4.378 · Cited by 649
DNA topology and its biological effects
(1991) · Choice Reviews Online · doi:10.5860/choice.28-3289 · Cited by 604
Encyclopedia of biological chemistry
(2013) · Choice Reviews Online · doi:10.5860/choice.51-0034 · Cited by 558
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
Fluoroquinolone Antimicrobial Agents
Hooper, D. C., & Wolfson, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240606 · Cited by 548
Etoposide, Topoisomerase II and Cancer
Baldwin, E., & Osheroff, N. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011054222364 · Cited by 520
Self-citationTumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T.-K., & Liu, L. F. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 508
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Self-citationWoessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K., & Drake, F. H. (1991) · PubMed · Cited by 455
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T., & Mirabelli, C. K. (1989) · Biochemistry · doi:10.1021/bi00446a029 · Cited by 410
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
Heck, M. M., Hittelman, W. N., & Earnshaw, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1086 · Cited by 409
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., & Rowley, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070061297 · Cited by 390
Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. M., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C. M., & Wang, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7177 · Cited by 389
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
Fortune, J. M., & Osheroff, N. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)64006-0 · Cited by 366
Self-citationMLL: a histone methyltransferase disrupted in leukemia
Hess, J. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.005 · Cited by 360
Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues.
Nakamura, J., & Swenberg, J. A. (1999) · PubMed · Cited by 358
Benzene and the Dose-Related Incidence of Hematologic Neoplasms in China
Hayes, R. B., Dosemeci, M., Wacholder, S., Travis, L. B., Rothman, N., Hoover, R. N., Linet, M. S., Yin, S. N., Li, G.-L., & Li, C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1065 · Cited by 349
DNA Topoisomerase IIβ and Neural Development
Yang, X., Li, W., Prescott, E. D., Burden, S. J., & Wang, J. C. (2000) · Science · doi:10.1126/science.287.5450.131 · Cited by 344
Investigating the biological functions of DNA topoisomerases in eukaryotic cells
Nitiss, J. L. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00128-6 · Cited by 321
Roca, J., & Wang, J. C. (1992) · Cell · doi:10.1016/0092-8674(92)90558-t · Cited by 317
Protection against breast cancer with genistein: a component of soy
Lamartiniere, C. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1705s · Cited by 314
Larson, R. A., Wang, Y., Banerjee, M., Wiemels, J., Hartford, C., Beau, M. M. L., & Smith, M. T. (1999) · Blood · doi:10.1182/blood.v94.2.803 · Cited by 304
Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.
Sander, M., & Hsieh, T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82081-x · Cited by 285
DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia
Mistry, A. R., Felix, C. A., Whitmarsh, R. J., Mason, A., Reiter, A., Cassinat, B., Parry, A., Walz, C., Wiemels, J. L., Segal, M. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042715 · Cited by 281
Self-citationCell death induced by topoisomerase-targeted drugs: more questions than answers
Kaufmann, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00136-5 · Cited by 278
Drake, F., Zimmerman, J., McCabe, F., Bartus, H., Per, Sr., Sullivan, D., Ross, W., Mattern, M., Johnson, R., & Crooke, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49317-9 · Cited by 277
Classen, S., Olland, S., & Berger, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832879100 · Cited by 263
Barnes, S., Peterson, T. G., & Coward, L. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590823 · Cited by 257
Worland, S. T., & Wang, J. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83757-7 · Cited by 251
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
Hsiang, Y. H., Wu, H. Y., & Liu, L. F. (1988) · PubMed · Cited by 247
Human DNA topoisomerase I: relaxation, roles, and damage control
Leppard, J. B., & Champoux, J. J. (2005) · Chromosoma · doi:10.1007/s00412-005-0345-5 · Cited by 233
Heat-induced depyrimidination of deoxyribonucleic acid in neutral solution
Lindahl, T., & Karlstrom, O. (1973) · Biochemistry · doi:10.1021/bi00749a020 · Cited by 229
Osheroff, N. (1989) · Biochemistry · doi:10.1021/bi00441a005 · Cited by 226
Self-citationEukaryotic topoisomerase II. Characterization of enzyme turnover.
Osheroff, N. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67607-0 · Cited by 206
Self-citationSpector, L. G., Xie, Y., Robison, L. L., Heerema, N. A., Hilden, J. M., Lange, B., Felix, C. A., Davies, S. M., Slavin, J., Potter, J. D., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0602 · Cited by 200
Leukemias related to treatment with DNA topoisomerase II inhibitors*
Felix, C. A. (2001) · Medical and Pediatric Oncology · doi:10.1002/mpo.1125 · Cited by 191
Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde
Anderson, V., & Osheroff, N. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398013 · Cited by 190
Self-citationPhysiological regulation of eukaryotic topoisomerase II
Isaacs, R. J., Davies, S. L., Sandri, M. I., Redwood, C., Wells, N. J., & Hickson, I. D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00131-6 · Cited by 186
The Structure of Supercoiled Intermediates in DNA Replication
Peter, B. J., Ullsperger, C., Hiasa, H., Marians, K. J., & Cozzarelli, N. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81740-7 · Cited by 184
Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiae
Kim, R. A., & Wang, J. C. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90387-2 · Cited by 176
Human Topoisomerase IIα Rapidly Relaxes Positively Supercoiled DNA
McClendon, A. K., Rodriguez, A. C., & Osheroff, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503320200 · Cited by 176
Self-citationThe Structural Basis for Substrate Specificity in DNA Topoisomerase IV
Corbett, K. D., Schoeffler, A. J., Thomsen, N. D., & Berger, J. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.029 · Cited by 173
Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene.
Smith, M. T., Zhang, L., Wang, Y., Hayes, R. B., Li, G., Wiemels, J. L., Dosemeci, M., Titenko-Holland, N. V., Xi, L., Kolachana, P., et al. (1998) · PubMed · Cited by 171
Austin, C. A., Patel, S., Ono, K., Nakane, H., & Fisher, L. M. (1992) · Biochemical Journal · doi:10.1042/bj2820883 · Cited by 170
HOX genes: seductive science, mysterious mechanisms.
Lappin, T. R. J., Grier, D. G., Thompson, A., & Halliday, H. L. (2006) · PubMed Central · Cited by 169
Bioflavonoids as Poisons of Human Topoisomerase IIα and IIβ
Bandele, O. J., & Osheroff, N. (2007) · Biochemistry · doi:10.1021/bi7000664 · Cited by 167
Self-citationThe C-terminal domain of DNA gyrase A adopts a DNA-bending β-pinwheel fold
Corbett, K. D., Shultzaberger, R. K., & Berger, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401595101 · Cited by 166
On the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II.
Lindsley, J. E., & Wang, J. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53067-2 · Cited by 159
Wiley encyclopedia of molecular medicine
Kazazian, H. H. (2002) · Medical Entomology and Zoology · Cited by 158
DNA Topoisomerase II as a Target for Cancer Chemotherapy
Walker, J. V., & Nitiss, J. L. (2002) · Cancer Investigation · doi:10.1081/cnv-120002156 · Cited by 157
Stimulation of Topoisomerase II-Mediated DNA Damage via a Mechanism Involving Protein Thiolation
Wang, H., Mao, Y., Chen, A. Y., Zhou, N., LaVoie, E. J., & Liu, L. F. (2001) · Biochemistry · doi:10.1021/bi002786j · Cited by 152
Burden, D. A., Kingma, P. S., Froelich-Ammon, S. J., Bjornsti, M., Patchan, M. W., Thompson, R. B., & Osheroff, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29238 · Cited by 149
Self-citationThe Role of Genistein and Synthetic Derivatives of Isoflavone in Cancer Prevention and Therapy
Sarkar, F. H., Adsule, S., Padhyé, S., Kulkarni, S., & Li, Y. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706776361439 · Cited by 148
Robinson, M. J., Martin, B. A., Gootz, T. D., McGuirk, P. R., Moynihan, M. S., Sutcliffe, J. A., & Osheroff, N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98726-0 · Cited by 145
Self-citationTopoisomerase II and the etiology of chromosomal translocations
Felix, C. A., Kolaris, C. P., & Osheroff, N. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.031 · Cited by 145
Self-citationSmith, M. T., Wang, Y., Skibola, C. F., Slater, D. J., Nigro, L. L., Nowell̀, P. C., Lange, B. J., & Felix, C. A. (2002) · Blood · doi:10.1182/blood-2001-12-0264 · Cited by 141
Topoisomerase II drives DNA transport by hydrolyzing one ATP
Baird, C. L., Harkins, T. T., Morris, S. K., & Lindsley, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13685 · Cited by 141
Redox Properties of Tea Polyphenols and Related Biological Activities
Sang, S., Hou, Z., Lambert, J. D., & Yang, C. S. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1704 · Cited by 140
A topological view of the replicon
Schvartzman, J. B., & Stasiak, A. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400101 · Cited by 136
Andersen, M. K., Christiansen, D. H., Jensen, B. A., Ernst, P., Hauge, G., & Pedersen-Bjergaard, J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03000.x · Cited by 136
Beneficial effects of tea and its polyphenols against prostate cancer
Siddiqui, I. A., Adhami, V. M., Saleem, M., & Mukhtar, H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500113 · Cited by 134
A Perspective on Benzene Leukemogenesis
Snyder, R. L., & Kali, G. F. (1994) · Critical Reviews in Toxicology · doi:10.3109/10408449409021605 · Cited by 133
Topoisomerase IV, alone, unknots DNA in E. coli
Deibler, R. W., Rahmati, S., & Zechiedrich, L. (2001) · Genes & Development · doi:10.1101/gad.872301 · Cited by 132
Zechiedrich, L., Christiansen, K., Andersen, A. H., Westergaard, O., & Osheroff, N. (1989) · Biochemistry · doi:10.1021/bi00441a014 · Cited by 126
Self-citationAntioxidant Actions of Polyphenols in Humans
Dragsted, L. O. (2003) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.73.2.112 · Cited by 118
Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver
Swenberg, J. A., Fedtke, N., Ciroussel, F., Barbin, A., & Bartsch, H. (1992) · Carcinogenesis · doi:10.1093/carcin/13.4.727 · Cited by 114
Libura, J., Slater, D. J., Felix, C. A., & Richardson, C. A. (2004) · Blood · doi:10.1182/blood-2004-07-2683 · Cited by 112
Structural similarities between topoisomerases that cleave one or both DNA strands
Berger, J. M., Fass, D., Wang, J. C., & Harrison, S. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7876 · Cited by 110
Sabourin, M., & Osheroff, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.9.1947 · Cited by 105
Self-citationChromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
Felix, C. A., Lange, B. J., Hosler, M. R., Fertala, J., & Bjornsti, M. (1995) · PubMed · Cited by 101
Chow, K., MACDONALD, T. L., & Ross, W. E. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09769-x · Cited by 101
Betti, C. J., Villalobos, M. J., Díaz, M. O., & Vaughan, A. T. (2001) · PubMed · Cited by 99
Benzene, NQO1, and genetic susceptibility to cancer
Smith, M. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7624 · Cited by 98
Mechanisms of Transformation by MLL
Hess, J. L. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.i4.10 · Cited by 92
Tenney, K., & Shilatifard, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20421 · Cited by 92
Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II.
Shiozaki, K., & Yanagida, M. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.5.1023 · Cited by 92
Lovett, B. D., Strumberg, D., Blair, I. A., Pang, S., Burden, D. A., Megonigal, M. D., Rappaport, E. F., Rebbeck, T. R., Osheroff, N., Pommier, Y. G., et al. (2001) · Biochemistry · doi:10.1021/bi002361x · Cited by 89
Self-citationLee, S. H., Oe, T., & Blair, I. A. (2002) · Chemical Research in Toxicology · doi:10.1021/tx010147j · Cited by 88
Chromosomal Instability in Amniocytes From Fetuses of Mothers Who Smoke
de la Chica, R. A., Ribas, I., Giraldo, J., Egozcue, J., & Fuster, C. (2005) · JAMA · doi:10.1001/jama.293.10.1212 · Cited by 87
Lovett, B. D., Nigro, L. L., Rappaport, E. F., Blair, I. A., Osheroff, N., Zheng, N., Megonigal, M. D., Williams, W. R., Nowell̀, P. C., & Felix, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171309898 · Cited by 83
Self-citationThe response of eukaryotic topoisomerases to DNA damage
Kingma, P. S., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00138-9 · Cited by 82
Self-citationInterfacial Inhibitors of Protein-Nucleic Acid Interactions
Pommier, Y. G., & Marchand, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054222337 · Cited by 74
DNA topoisomerase II mutations and resistance to anti‐tumor drugs
Vassetzky, Y. S., Alghisi, G., & Gasser, S. M. (1995) · BioEssays · doi:10.1002/bies.950170906 · Cited by 74
Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.
Betti, C. J., Villalobos, M. J., Dı́az, M. O., & Vaughan, A. T. (2003) · PubMed · Cited by 73
N-Acetyl-p-benzoquinone Imine, the Toxic Metabolite of Acetaminophen, Is a Topoisomerase II Poison
Bender, R. P., Lindsey, R. H., Burden, D. A., & Osheroff, N. (2004) · Biochemistry · doi:10.1021/bi036107r · Cited by 70
Self-citationRadiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review
Pedersen-Bjergaard, J. (1992) · Leukemia Research · doi:10.1016/0145-2126(92)90102-d · Cited by 68
Cells Lacking DNA Topoisomerase IIβ are Resistant to Genistein
López‐Lázaro, M., Willmore, E., & Austin, C. A. (2007) · Journal of Natural Products · doi:10.1021/np060609z · Cited by 65
Elsea, S. H., McGuirk, P. R., Gootz, T. D., Moynihan, M. S., & Osheroff, N. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2179 · Cited by 64
Self-citationBipartite Nuclear Localization Signals in the C Terminus of Human Topoisomerase IIα
Mirski, S. E. L., Gerlach, J. H., Cummings, H. J., Zirngibl, R. A., Greer, P. A., & Cole, S. P. C. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3805 · Cited by 60
Sung, P., Libura, J., & Richardson, C. A. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.018 · Cited by 58
Khan, Q. A., Kohlhagen, G., Marshall, R., Austin, C. A., Kalena, G. P., Kroth, H., Sayer, J. M., Jerina, D. M., & Pommier, Y. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2032456100 · Cited by 41
Gentry, A. C., & Osheroff, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00246-2 · Cited by 41
Self-citationDNA Abasic Lesions in a Different Light: Solution Structure of an Endogenous Topoisomerase II Poison
Cline, S. D., Jones, W. R., Stone, M. P., & Osheroff, N. (1999) · Biochemistry · doi:10.1021/bi991750s · Cited by 36
Self-citationOsheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00123-7 · Cited by 36
Self-citationVélez-Cruz, R., Riggins, J. N., Daniels, J. S., Cai, H., Guengerich, F. P., Marnett, L. J., & Osheroff, N. (2005) · Biochemistry · doi:10.1021/bi0478289 · Cited by 35
Self-citationEating to beat breast cancer: Potential role for soy supplements
Stoll, B. A. (1997) · Annals of Oncology · doi:10.1023/a:1008237505645 · Cited by 34
Cline, S. D., & Osheroff, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29740 · Cited by 33
Self-citationPositioning the 3′-DNA Terminus for Topoisomerase II-mediated Religation
Wilstermann, A. M., & Osheroff, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100197200 · Cited by 14
Self-citationChampoux, J. J. (2013) · Encyclopedia of Biological Chemistry · doi:10.1016/b978-0-12-378630-2.00245-0 · Cited by 2
Cited by
Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Pommier, Y. (2009) · Chemical Reviews · doi:10.1021/cr900097c · Cited by 707
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Podhorecka, M., Skladanowski, A., & Bozko, P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/920161 · Cited by 612
Flavonoids as prospective compounds for anti-cancer therapy
Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, H. M. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.004 · Cited by 572
Metadata
- Authors
- McClendon, A. K., & Osheroff, N.
- Venue
- Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 623
- Issue
- 1-2
- Pages
- 83-97
- ISSN
- 0027-5107 (ISSN-L)
- 1386-1964
- OpenAlex
- W2069151403
- Cited by
- 406
- References
- 116
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.